Company Filing History:
Years Active: 2018
Title: Nadja Prang: Innovator in Polypeptide Compositions
Introduction
Nadja Prang is a distinguished inventor based in Rome, Italy. She has made significant contributions to the field of biotechnology, particularly in the development of polypeptide compositions. Her innovative work focuses on creating compositions that can specifically bind predetermined antigens, which has important implications for medical research and therapeutic applications.
Latest Patents
Nadja Prang holds a patent for her invention titled "Compositions comprising polypeptides." This patent describes compositions that include polypeptides capable of specifically binding to predetermined antigens. The polypeptide in her composition features at least two antigen binding sites located on a single polypeptide chain. Notably, one of these binding sites specifically targets the human CD3 antigen. The polypeptide can exist in both monomeric and multimeric forms, with the multimeric form constituting no more than 5% of the total weight of the combined forms.
Career Highlights
Nadja Prang is currently employed at Amgen Research (Munich) GmbH, where she continues to advance her research in biotechnology. Her work has garnered attention for its potential applications in immunology and therapeutic development. With her expertise, she is contributing to the understanding of antigen interactions and their implications for disease treatment.
Collaborations
Nadja collaborates with notable colleagues, including Robert Hofmeister and Andreas Wolf. These partnerships enhance her research efforts and foster innovation within her field.
Conclusion
Nadja Prang is a pioneering inventor whose work in polypeptide compositions is paving the way for advancements in medical research. Her contributions are vital to the ongoing exploration of therapeutic solutions.